Deepest sympathy for your loss, nt.
I share your view of Imugene. I do believe they are absolutely genuine and passionate about their research. I also have done quite a lot of reading over the past couple of years and sought advice from people with better science quals than my own. There is no sure bet in this - but the science they are pursuing is sound, and potentially a game changer. I get the feeling that immortality would be a bad outcome for humanity (personal view here), but there is no doubt that if science can reduce the misery and suffering and premature mortality which comes from cancer, then that will be a wonderful thing.
Someone else mentioned ethical investment on this forum earlier today. I think Imugene fits that category very nicely, as well as being a potentially outstanding investment in financial terms as well. That's a rare and compelling combination.
2018 is definitely the year Imugene will grab the attention it deserves. What we are seeing now is just the start.
Sure, it could all end in tears like PBT did - don't bet the farm on pharma (or anything else for that matter) - but my confidence in IMU has been steadily growing and I do feel the risk is less than usual for a biotech. IMU is officially a very junior biotech - but they have the expertise and IP of a much larger and more mature outfit.
This could be an outstanding story.....
Good luck to you, and all other Imugeners.
Cheers
Dave
